Balaji Amines Ltd

Balaji Amines Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Balaji Amines Ltd

₹ 1,894 -4.94%
29 Jun 3:48 p.m.
balajiamines.com BSE: 530999 NSE: BALAMINES
About

Incorporate in 1989, Balaji Amines Ltd is engaged in manufacturing of specialty chemicals, aliphatic amines, and derivatives, along with ownership of a five-star hotel in Solapur, Maharashtra.[1]

Key Points

Market Leadership[1]
The Company is the largest manufacturer of aliphatic amines and methylamines in India, the only domestic company to develop indigenous amines manufacturing technology, and the sole Indian producer of several specialty chemicals

Website BSE NSE
  • Market Cap ₹ 6,135 Cr.
  • Current Price ₹ 1,894
  • High / Low ₹ 2,288 / 905
  • Stock P/E 37.1
  • Book Value ₹ 551
  • Dividend Yield 0.56 %
  • ROCE 13.3 %
  • ROE 9.61 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 21.7%

Cons

  • Stock is trading at 3.50 times its book value
  • The company has delivered a poor sales growth of 0.95% over past five years.
  • Company has a low return on equity of 10.3% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals

Part of BSE Commodities Nifty Microcap 250 Nifty Total Market BSE 1000 Nifty Smallcap 500

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
347 337 325 308 367 333 320 299 322 319 309 301 362
292 286 277 250 278 274 262 248 264 263 259 246 276
Operating Profit 55 52 48 58 89 59 58 52 58 56 50 55 86
OPM % 16% 15% 15% 19% 24% 18% 18% 17% 18% 18% 16% 18% 24%
4 4 5 6 6 5 6 5 6 7 7 5 8
Interest 0 0 1 1 1 0 1 0 0 0 0 0 1
Depreciation 8 8 8 8 9 9 9 10 10 11 12 12 11
Profit before tax 51 47 44 56 85 55 54 47 53 52 45 48 82
Tax % 26% 27% 26% 25% 26% 26% 26% 24% 25% 24% 30% 32% 25%
38 34 33 42 63 41 40 36 40 40 31 32 62
EPS in Rs 11.64 10.64 10.09 12.82 19.32 12.51 12.47 11.02 12.22 12.28 9.71 10.01 19.10
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
602 632 665 858 947 918 1,227 1,914 1,720 1,330 1,266 1,287
500 503 513 676 753 738 901 1,473 1,391 1,083 1,040 1,040
Operating Profit 102 129 151 182 193 180 327 441 330 247 226 247
OPM % 17% 20% 23% 21% 20% 20% 27% 23% 19% 19% 18% 19%
3 2 9 12 5 10 12 18 10 21 23 28
Interest 31 20 12 9 13 12 5 7 3 2 2 2
Depreciation 19 18 18 19 20 24 23 29 31 34 38 46
Profit before tax 56 93 130 166 166 154 310 423 305 232 209 227
Tax % 35% 34% 34% 32% 29% 26% 25% 27% 25% 26% 25% 27%
36 61 86 113 118 114 232 308 228 171 156 166
EPS in Rs 11.22 18.91 26.41 34.93 36.44 35.11 71.51 95.04 70.23 52.87 48.21 51.09
Dividend Payout % 11% 11% 8% 7% 8% 9% 6% 6% 14% 21% 23% 22%
Compounded Sales Growth
10 Years: 7%
5 Years: 1%
3 Years: -9%
TTM: 2%
Compounded Profit Growth
10 Years: 10%
5 Years: -6%
3 Years: -10%
TTM: 6%
Stock Price CAGR
10 Years: 22%
5 Years: -6%
3 Years: -5%
1 Year: 11%
Return on Equity
10 Years: 17%
5 Years: 14%
3 Years: 10%
Last Year: 10%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 6 6 6 6 6 6 6 6 6 6 6 6
Reserves 231 285 371 461 569 661 891 1,186 1,394 1,528 1,649 1,778
236 159 103 115 95 102 0 0 0 0 0 0
129 156 175 237 327 334 394 292 151 202 195 238
Total Liabilities 603 607 655 819 997 1,104 1,292 1,484 1,551 1,736 1,850 2,024
321 322 309 316 318 363 344 495 604 724 833 883
CWIP 3 16 25 66 63 46 173 141 74 143 154 203
Investments 30 30 30 66 66 114 66 66 128 66 66 66
249 238 292 371 550 581 708 782 745 803 797 872
Total Assets 603 607 655 819 997 1,104 1,292 1,484 1,551 1,736 1,850 2,024

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
60 84 72 126 89 148 94 176 187 217 224 200
-14 -30 -23 -93 -47 -130 -87 -142 -155 -190 -179 -129
-49 -52 -54 -29 -29 -31 3 -20 -22 -35 -38 -36
Net Cash Flow -3 2 -5 4 13 -13 10 14 10 -8 8 35
Free Cash Flow 52 51 59 58 70 95 -37 28 111 -5 67 56
CFO/OP 68% 75% 65% 93% 72% 111% 40% 64% 78% 107% 117% 95%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 70 69 67 73 64 76 81 83 55 72 71 84
Inventory Days 93 62 88 70 100 66 56 69 97 127 129 111
Days Payable 46 57 55 56 58 40 43 57 13 35 34 26
Cash Conversion Cycle 117 74 100 87 106 102 94 95 139 164 166 169
Working Capital Days 2 6 31 29 46 46 80 80 98 118 117 112
ROCE % 19% 24% 30% 33% 29% 23% 38% 41% 24% 16% 13% 13%

Insights

In beta
Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Aliphatic Amines Sales Volume
MT

Log in to view insights

Please log in to see hidden values.

Login
Amine Derivatives Sales Volume
MT
Consolidated Sales Volume
MT
Specialty Chemicals Sales Volume
MT
N-Butylamine Capacity Utilization
%
Total Installed Capacity
TPA

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
53.71% 53.71% 53.71% 53.71% 53.71% 53.71% 53.71% 54.62% 54.59% 54.59% 54.59% 54.59%
4.55% 4.52% 4.58% 4.92% 5.05% 5.27% 5.16% 5.09% 5.00% 4.53% 3.30% 2.99%
0.18% 0.90% 1.43% 1.48% 1.59% 1.79% 1.66% 1.48% 1.46% 1.52% 1.53% 1.46%
41.57% 40.88% 40.31% 39.91% 39.67% 39.23% 39.46% 38.83% 38.96% 39.37% 40.59% 40.96%
No. of Shareholders 1,40,9571,44,9901,41,4171,38,0171,32,4281,29,1601,29,3611,27,4421,21,9501,18,8941,17,5911,15,754

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls